Molecular study of human herpesvirus 6 and 8 involvement in coronary atherosclerosis and coronary instability

Journal of Medical Virology

Volumn 84, Issue 12, 2012, Pages 1961-1966

  Magnoni, Marco ^a,b   Malnati, Mauro ^a   Cristell, Nicole ^a   Coli, Stefano ^a   Russo, Domenico ^a   Ruotolo, Giacomo ^a   Cianflone, Domenico ^a   Alfieri, Ottavio ^a   Lusso, Paolo ^a   Maseri, Attilio ^a,b  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^b Heart Care Foundation   (Italy)

Author keywords

Acute coronary syndrome; Atherosclerosis; Infection; Virus

Indexed keywords

ACUTE HEART INFARCTION; ADULT; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DNA EXTRACTION; DNA VIRUS; ENDOTHELIUM; EXANTHEMA SUBITUM; FEMALE; HEART DISEASE; HEART VALVE REPLACEMENT; HUMAN; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 8; HUMAN TISSUE; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; REAL TIME POLYMERASE CHAIN REACTION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TROPISM; VIREMIA;

AGED; CORONARY ARTERY DISEASE; CORONARY VESSELS; CROSS-SECTIONAL STUDIES; DNA, VIRAL; FEMALE; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 6, HUMAN; HERPESVIRUS 8, HUMAN; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREVALENCE; REAL-TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; VIRAL LOAD; VIREMIA;

EID: 84867705913     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.23355     Document Type: Article

References (44)

1. Andraws R, Berger JS, Brown DL. 2005. Effects of antibiotic therapy on outcomes in patients with coronary artery disease: A mea-analysis of randomized controlled trials. J Am Med Assoc 293:2641-2647.
2. Antman K, Chang Y. 2000. Kaposi's sarcoma. N Engl J Med 342:1027-1038.
3. Arbustini E, De Servi S, Bramucci E, Porcu E, Costante AM, Grasso M, Diegoli M, Fasani R, Morbini P, Angoli L, Boscarini M, Repetto S, Danzi GB, Nicoli L, Campolo L, Lucreziotti S, Specchia G. 1995. Comparison of coronary lesions obtained by directional coronary atherectomy in unstable angina, stable angina, and restenosis after either atherectomy or angioplasty. Am J Cardiol 75:675-682.
4. Biswas P, Mantelli B, Sica A, Malnati M, Panzeri C, Saccani A, Hasson H, Vecchi A, Saniabadi A, Lusso P, Lazzarin A, Beretta A. 2003. Expression of CD4 on human peripheral blood neutrophils. Blood 101:4452-4456.
5. Broccolo F, Locatelli G, Sarmati L, Piergiovanni S, Veglia F, Andreoni M, Buttò S, Ensoli B, Lusso P, Malnati MS. 2002. Calibrated real-time PCR assay for quantitation of human herpesvirus 8 DNA in biological fluids. J Clin Microbiol 40:4652-4658.
6. Broccolo F, Drago F, Paolino S, Cassina G, Gatto G, Fusetti L, Matteoli B, Zaccaria E, Parodi A, Lusso P, Ceccherini-Nelli L, Malnati MS. 2009. Reactivation of human herpesvirus 6 (HHV-6) infection in patients with connective tissue disorders. J Clin Virol 46:43-46.
7. Butler LM, Jeffery HC, Wheat RL, Rae PC, Townsend K, Alkharsah R, Schultz TF, Nash GB, Blackbourn DJ. 2011. Kaposi's sarcoma-associated herpesvirus infection of endothelial cells inhibits neutrophil recruitment through an interleukin-6-dependent mechanism: A new paradigm for viral immune evasion. J Virol 85:7321-7332.
8. Caligiuri G, Liuzzo G, Biasucci LM, Maseri A. 1998. Immune system activation follows inflammation in unstable angina, pathogenetic implications. J Am Coll Cardiol 32:1295-1304.
9. Caruso A, Rotola A, Comar M, Favilli F, Galvan M, Tosetti M, Campello C, Caselli E, Alessandri G, Grassi M, Garrafa E, Cassai E, Di Luca D. 2002. HHV-6 infects human aortic and heart microvascular endothelial cells increasing their ability to secrete proinflammatory chemokines. J Med Virol 67:528-533.
10. Caruso A, Favilli F, Rotola A, Comar M, Horejsh D, Alessandri G, Grassi M, Di Luca D, Fiorentini S. 2003. Human herpesvirus-6 modulates RANTES production in primary human endothelial cell cultures. J Med Virol 70:451-458.
11. Ciufo DM, Cannon JS, Poole LJ, Wu FY, Murray P, Ambinder RF, Hayward GS. 2001. Spindle cell conversion by Kaposi's sarcoma-associated herpesvirus: Formation of colonies and plaques with mixed lytic and latent gene expression in infected primary dermal microvascular endothelial cell cultures. J Virol 75:5614-5626.
12. Flamand L, Gosselin J, D'Addario M, Hiscott J, Ablashi DV, Gallo RC, Menezes J. 1991. Human herpesvirus 6 induces interleukin-1 beta and tumor necrosis factor alpha, but not interleukin-6, in peripheral blood mononuclear cell cultures. J Virol 65:5105-5110.
13. Flore O, Rafii S, Ely S, O'Leary JJ, Hyjek EM, Cesarman E. 1998. Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus. Nature 394:588-592.
14. Grahame-Clarke C. 2005. Human cytomegalovirus, endothelial function and atherosclerosis. Herpes 12:42-45.
15. Grivel JC, Ito Y, Fagà G, Santoro F, Shaheen F, Malnati MS, Fitzgerald W, Lusso P, Margolis L. 2001. Suppression of CCR5- but not CXCR4-tropic HIV-1 in lymphoid tissue by human herpesvirus 6. Nat Med 7:1232-1235.
16. Gupta S, Leatham EW, Carrington D, Mendall MA, Kaski JC, Camm AJ. 1997. Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction. Circulation 96:404-407.
17. Hansson GK. 2005. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 352:1685-1695.
18. Kol A, Sperti G, Shani J, Schulhoff N, van de Greef W, Landini MP, La Placa M, Maseri A, Crea F. 1995. Cytomegalovirus replication is not a cause of instability in unstable angina. Circulation 91:1910-1913.
19. Kühl U, Pauschinger M, Noutsias M, Seeberg B, Bock T, Lassner D, Poller W, Kandolf R, Schultheiss HP. 2005. High prevalence of viral genomes and multiple viral infections in the myocardium of adults with "idiopathic" left ventricular dysfunction. Circulation 111: 887-893.
20. Locatelli G, Santoro F, Veglia F, Gobbi A, Lusso P, Malnati M. 2000. Real-time quantitative PCR for human herpesvirus 6 DNA. J Clin Microbiol 38:4042-4048.
21. Luka J, Elfath MD, Dumont LJ. 2006. Seasonal reactivation of human herpesvirus-6 in seropositive healthy blood donors. J Clin Virol 37:S106.
22. Lusso P. 1996. Human herpesvirus 6. Antivir Res 31:1-21.
23. Lusso P, Markham PD, Tschachler E, di Marzo Veronese F, Salahuddin SZ, Ablashi DV, Pahwa S, Krohn K, Gallo RC. 1988. In vitro cellular tropism of human B-lymphotropic virus (human herpesvirus-6). J Exp Med 167:1659-1670.
24. Mahrholdt H, Wagner A, Deluigi CC, Kispert E, Hager S, Meinhardt G, Vogelsberg H, Fritz P, Dippon J, Bock CT, Klingel K, Kandolf R, Sechtem U. 2006. Presentation, patterns of myocardial damage, and clinical course of viral myocarditis. Circulation 114:1581-1890.
25. Malnati M, Broccolo F, Nozza S, Sarmati L, Ghezzi S, Locatelli G, Delfanti F, Capiluppi B, Careddu A, Andreoni M, Monini P, Poli G, Lazzarin A, Lusso P, Tambussi G. 2002. Retrospective analysis of HHV-8 viremia and cellular viral load in HIV-seropositive patients receiving interleukin 2 in combination with antiretroviral therapy. Blood 100:1575-1578.
26. Malnati MS, Scarlatti G, Gatto F, Salvatori F, Cassina G, Rutigliano T, Volpi R, Lusso P. 2008. A universal real-time PCR assay for the quantification of group-M HIV-1 proviral load. Nat Protoc 3:1240-1248.
27. Maseri A, Cianflone D. 2002. Inflammation in acute coronary syndrome, Eur Heart J 4:8-13.
28. Mehta JL, Saldeen TG, Rand K. 1998. Interactive role of infection, inflammation and traditional risk factors in atherosclerosis and coronary artery disease. J Am Coll Cardiol 31:1217-1225.
29. Mendall MA, Carrington D, Strachan D, Patel P, Molineaux N, Levi J, Toosey T, Camm AJ, Northfield TC. 1995. Chlamydia pneumoniae, risk factors for seropositivity and association with coronary heart disease. J Infect 30:121-128.
30. Mesri EA, Cesarman E, Arvanitakis L, Rafii S, Moore MA, Posnett DN, Knowles DM, Asch AS. 1996. Human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus is a new transmissible virus that infects B cells. J Exp Med 183:2385-2390.
31. Neri Serneri GG, Prisco D, Martini F, Gori AM, Brunelli T, Poggesi L, Rostagno C, Gensini GF, Abbate R. 1997. Acute T-cell activation is detectable in unstable angina. Circulation 95:1806-1812.
32. Nomura S, Uehata S, Saito S, Osumi K, Ozeki Y, Kimura Y. 2003. Enzyme immunoassay detection of platelet-derived microparticles and RANTES in acute coronary syndrome. Thromb Haemost 89:506-512.
33. Pasceri V, Cammarota G, Patti G, Cuoco L, Gasbarrini A, Grillo RL, Fedeli G, Gasbarrini G, Maseri A. 1998. Association of virulent Helicobacter pylori strains with ischemic heart disease. Circulation 97:1675-1679.
34. Patel P, Mendall MA, Carrington D, Strachan DP, Leatham E, Molineaux N, Levy J, Blakeston C, Seymour CA, Camm AJ, Northfield TC. 1995. Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. Br Med J 311:711-714.
35. Razonable RR, Fanning C, Brown RA, Espy MJ, Rivero A, Wilson J, Kremers W, Smith TF, Paya CV. 2002. Selective reactivation of human herpesvirus 6 variant A occurs in critically Ill immunocompetent hosts. J Infect Dis 185:110-113.
36. Regnström J, Jovinge S, Båvenholm P, Ericsson CG, De Faire U, Hamsten A, Hellenius ML, Nilsson J, Tornvall P. 1998. Helicobacter pylori seropositivity is not associated with inflammatory parameters, lipid concentrations and degree of coronary artery disease. Intern Med 243:109-113.
37. Rotola A, Di Luca D, Cassai E, Ricotta D, Giulio A, Turano A, Caruso A, Muneretto C. 2000. Human herpesvirus 6 infects and replicates in aortic endothelium. J Clin Microbiol 38:3135-3136.
38. Secchiero P, Carrigan DR, Asano Y, Benedetti L, Crowley RW, Komaroff AL, Gallo RC, Lusso P. 1995. Detection of human herpesvirus 6 in plasma of children with primary infection and immunosuppressed patients by polymerase chain reaction. Infect Dis 171:273-280.
39. Serneri GG, Abbate R, Gori AM, Attanasio M, Martini F, Giusti B, Dabizzi P, Poggesi L, Modesti PA, Trotta F. 1992. Transient intermittent lymphocyte activation is responsible for the instability of angina. Circulation 86:790-797.
40. Stassen FR, Vainas T, Bruggeman CA. 2008. Infection and atherosclerosis. An alternative view on an outdated hypothesis. Pharmacol Rep 60:85-92.
41. Takatsuka H, Wakae T, Mori A, Okada M, Fujimori Y, Takemoto Y, Okamoto T, Kanamaru A, Kakishita E. 2003. Endothelial damage caused by cytomegalovirus and human herpesvirus-6. Bone Marrow Transplant 31:475-479.
42. Vallbracht KB, Schwimmbeck PL, Kühl U, Seeberg B, Schultheiss HP. 2004. Endothelium-dependent flow-mediated vasodilation of systemic arteries is impaired in patients with myocardial virus persistence. Circulation 110:2938-2945.
43. Vallbracht KB, Schwimmbeck PL, Kühl U, Rauch U, Seeberg B, Schultheiss HP. 2005. Differential aspects of endothelial function of the coronary microcirculation considering myocardial virus persistence, endothelial activation, and myocardial leukocyte infiltrates. Circulation 111:1784-1791.
44. Zhou YF, Leon MB, Waclawiw MA, Popma JJ, Yu ZX, Finkel T, Epstein SE. 1996. Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy. N Engl J Med 335:624-630.